Full text loading...
- ISSN: 1381-6128
- E-ISSN: 1873-4286
-
From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights
- Source: Current Pharmaceutical Design, Volume 19, Issue 29, Sep 2013, p. 5239 - 5249
-
- 01 Sep 2013
Abstract
NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression.
© Bentham Science Publishers